GlassScriptPhysician profile
Chad Michael Mccall
NPI 1326278532
$2,797.30
in general payments reported to CMS, 2019-2025
9 companies · $27.51 in 2025
The $27.51 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $600 · 2022: $50.73 · 2023: $1,947 · 2024: $171 · 2025: $27.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,932 · Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,932.00 |
| Food and Beverage | $214.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,932.00 | 2023 | |
| Becton, Dickinson and Company | $454.30 | 2021-2024 | Bd Facslyric |
| Sysmex America, INC. | $207.73 | 2021-2022 | |
| Davol INC. | $111.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $27.51 | 2025 | |
| Adaptive Biotechnologies Corporation | $19.61 | 2024 | Clonoseq |
| Jazz Pharmaceuticals INC. | $16.18 | 2024 | |
| Merck Sharp & Dohme LLC | $15.27 | 2023 | Keytruda, Lynparza |
| Ortho-Clinical Diagnostics, INC. | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.